A randomized trial of peginteferon alfa-2b and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBeAg-positive chronic hepatitis B

被引：1
|
作者：
Chan, HLY
Leung, NWY
Hui, AY
Liew, CT
Chim, AML
Chan, FKL
Hung, LCT
Sung, JJY
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] Alice Ho Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2004年 / 40卷
关键词：
D O I：
10.1016/S0168-8278(04)90423-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
423
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [41] EARLY HBEAG LOSS DURING LAMIVUDINE THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS WITH ACUTE EXACERBATION
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2009, 50 (04) : 515A - 515A
  • [42] Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance
    Sun, J.
    Hou, J. -L.
    Xie, Q.
    Li, X. -H.
    Zhang, J. -M.
    Wang, Y. -M.
    Wang, H.
    Lai, J. -Y.
    Chen, S. -J.
    Jia, J. -D.
    Sheng, J. -F.
    Chan, H. L. Y.
    Wang, J. -F.
    Li, M. K. K.
    Jiang, M.
    Popescu, M.
    Sung, J. J. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) : 424 - 431
  • [43] Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
    Sokal, EM
    Kelly, DA
    Mizerski, J
    Badia, IB
    Areias, JA
    Schwarz, KB
    Vegnente, A
    Little, NR
    Gardener, SD
    Jonas, MM
    HEPATOLOGY, 2006, 43 (02) : 225 - 232
  • [44] Prospective randomized study comparing combination of pegylated interferon and lamivudine versus lamivudine monotherapy for chronic hepatitis B infection
    Sung, JJ
    Chan, HL
    Chan, FK
    Wong, ML
    Hui, AY
    Leung, NW
    HEPATOLOGY, 2002, 36 (04) : 628A - 628A
  • [45] Interferon plus lamivudine versus lamivudine monotherapy in patients with chronic hepatitis B anti-HBE positive
    Karatapanis, S
    Ketikoglou, I
    Skorda, L
    Manolakopoulos, S
    Komnianides, K
    Lisgos, F
    Psellas, C
    Kalderi, T
    Kipraios, D
    Kouvidou, C
    Spanos, E
    Artikis, V
    JOURNAL OF HEPATOLOGY, 2004, 40 : 127 - 128
  • [46] Higher efficacy of 'Sequential' therapy of lamivudine and interferon compared lamivudine monotherapy in HBeAg positive, chronic hepatitis B patients.
    Kazim, SN
    Wakil, SM
    Sarin, SK
    GASTROENTEROLOGY, 2002, 123 (01) : 67 - 67
  • [47] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
  • [48] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [49] MAINTENANCE OF VIROLOGIC RESPONSE DURING CONSOLIDATION THERAPY WITH LAMIVUDINE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Yoon, Ki Tae
    Kim, Yeong Muk
    Heo, Jeong
    Cho, Mong
    HEPATOLOGY, 2009, 50 (04) : 523A - 523A
  • [50] Interferon plus lamivudine in treatment of chronic hepatitis B in patients unresponsive to lamivudine monotherapy
    Panahi, M.
    Heydari, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S417 - S417
12345